Stay updated on LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Sign up to get notified when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T20:46:57.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3; the previous label v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T17:23:58.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Administrative updates include revision v3.4.2 and removal of revisions v3.4.1 and a government funding lapse notice; to avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:42:00.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A government funding lapse notice has been added to the page, clarifying operational status, and the site revision version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:25:36.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    A glossary toggle was added, and QC/FEAR-related metadata labels were updated to show 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', replacing the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T23:38:34.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:44:01.000Z thumbnail image

Stay in the know with updates to LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.